Guy Betts

1.6k total citations
26 papers, 1.1k citations indexed

About

Guy Betts is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Guy Betts has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Guy Betts's work include Salivary Gland Tumors Diagnosis and Treatment (8 papers), Head and Neck Cancer Studies (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Guy Betts is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (8 papers), Head and Neck Cancer Studies (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Guy Betts collaborates with scholars based in United Kingdom, United States and Netherlands. Guy Betts's co-authors include Catharine West, Jarrod J. Homer, Adrian L. Harris, Francesca M. Buffa, Harriet E. Gee, Jiannis Ragoussis, Shalini Patiar, Crispin Miller, N.J. Slevin and Anassuya Ramachandran and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

Guy Betts

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Betts United Kingdom 14 648 645 246 168 156 26 1.1k
Fo‐Ping Chen China 16 579 0.9× 567 0.9× 306 1.2× 184 1.1× 296 1.9× 29 1.1k
Qiuliang Wu China 16 407 0.6× 275 0.4× 446 1.8× 115 0.7× 131 0.8× 37 922
Kasper Toustrup Denmark 10 290 0.4× 515 0.8× 214 0.9× 269 1.6× 300 1.9× 17 926
Maria Vassilakopoulou Greece 14 267 0.4× 187 0.3× 383 1.6× 143 0.9× 78 0.5× 29 790
Charles Schneider United States 17 260 0.4× 282 0.4× 654 2.7× 301 1.8× 258 1.7× 45 993
Alex Guminski Australia 16 272 0.4× 201 0.3× 709 2.9× 445 2.6× 208 1.3× 35 1.1k
Masanori Someya Japan 18 277 0.4× 149 0.2× 348 1.4× 229 1.4× 52 0.3× 70 902
Jingfeng Zong China 19 335 0.5× 377 0.6× 566 2.3× 285 1.7× 716 4.6× 67 1.3k
Baochai Lin China 15 506 0.8× 470 0.7× 241 1.0× 244 1.5× 26 0.2× 26 903
Youling Gong China 21 439 0.7× 178 0.3× 534 2.2× 662 3.9× 89 0.6× 89 1.4k

Countries citing papers authored by Guy Betts

Since Specialization
Citations

This map shows the geographic impact of Guy Betts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Betts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Betts more than expected).

Fields of papers citing papers by Guy Betts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Betts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Betts. The network helps show where Guy Betts may publish in the future.

Co-authorship network of co-authors of Guy Betts

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Betts. A scholar is included among the top collaborators of Guy Betts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Betts. Guy Betts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Price, James, Hitesh Mistry, Guy Betts, et al.. (2022). Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer. Journal of Clinical Oncology. 40(20). 2203–2212. 16 indexed citations
4.
Feeney, Laura, Helen Adderley, Guy Betts, et al.. (2022). Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. Cancers. 14(5). 1133–1133. 9 indexed citations
5.
Price, James, Catharine West, Hitesh Mistry, et al.. (2021). Improved survival prediction for oropharyngeal cancer beyond TNMv8. Oral Oncology. 115. 105140–105140. 9 indexed citations
6.
Betts, Guy, et al.. (2021). Synchronous oral cavity malignancy in identical twins—unusual coincidence of similarities. International Journal of Oral and Maxillofacial Surgery. 51(5). 621–624. 2 indexed citations
7.
Metcalf, Robert, Becky M. Bola, David Morgan, et al.. (2020). ELLA01-1: A study to determine the utility of TP53 mutations as a prognostic biomarker in adenoid cystic carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 6585–6585.
8.
Adderley, Helen, Laura Feeney, Deborah Morgan, et al.. (2020). The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma. Oral Oncology. 113. 105095–105095. 18 indexed citations
9.
Little, Ross A., Yann Jamin, Jessica K.R. Boult, et al.. (2018). Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology. Radiology. 288(3). 739–747. 38 indexed citations
10.
Metcalf, Robert, Sumitra Mohan, Said Hilton, et al.. (2017). The application of liquid biopsies in metastatic salivary gland cancer to identify candidate therapeutic targets. Annals of Oncology. 28. vii8–vii8. 2 indexed citations
11.
Hall, John, Guy Betts, Gillian L. Hall, et al.. (2015). Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma. British Journal of Cancer. 113(6). 886–893. 119 indexed citations
12.
Thomson, David, Kean Fatt Ho, Linda Ashcroft, et al.. (2014). Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma. Acta Oncologica. 54(1). 88–98. 22 indexed citations
13.
Eustace, Amanda, Navin Mani, Paul N. Span, et al.. (2013). A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. Clinical Cancer Research. 19(17). 4879–4888. 167 indexed citations
14.
Ramachandran, Anassuya, Guy Betts, Christopher Blick, et al.. (2013). An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. European Journal of Cancer. 49(7). 1741–1751. 13 indexed citations
15.
Betts, Guy, Helen Valentine, R Swindell, et al.. (2013). FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 464(2). 145–156. 53 indexed citations
16.
Betts, Guy, Amanda Eustace, Shalini Patiar, et al.. (2012). Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma. European Journal of Cancer. 49(1). 156–165. 30 indexed citations
17.
Donaldson, Stephanie B., Guy Betts, S. Bonington, et al.. (2011). Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 81(4). 1176–1183. 54 indexed citations
18.
Gee, Harriet E., Francesca M. Buffa, Carlos Camps, et al.. (2011). The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. British Journal of Cancer. 104(7). 1168–1177. 238 indexed citations
19.
Gee, Harriet E., Carme Camps, Francesca M. Buffa, et al.. (2010). hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer. 116(9). 2148–2158. 196 indexed citations
20.
Möller‐Levet, Carla S., Guy Betts, Adrian L. Harris, et al.. (2009). Exon Array Analysis of Head and Neck Cancers Identifies a Hypoxia Related Splice Variant of LAMA3 Associated with a Poor Prognosis. PLoS Computational Biology. 5(11). e1000571–e1000571. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fo‐Ping Chen Breakdown of academic impact, for papers by Qiuliang Wu Breakdown of academic impact, for papers by Kasper Toustrup Breakdown of academic impact, for papers by Maria Vassilakopoulou Breakdown of academic impact, for papers by Charles Schneider Breakdown of academic impact, for papers by Alex Guminski Breakdown of academic impact, for papers by Masanori Someya Breakdown of academic impact, for papers by Jingfeng Zong Breakdown of academic impact, for papers by Baochai Lin Breakdown of academic impact, for papers by Youling Gong
Rankless by CCL
2026